1-3 of 3
Tao Geng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NKX101, an Allogeneic Off-the-Shelf CAR NK Cell Therapy Targeting NKG2D-Ls, Has Potent Anti-Leukemic Activity Alone or in Combination with Ara-C

Cynthia Cho, Kyle Hansen, Nikki Kimura, Jessica Sood, Damie Juat, Tao Geng, James Trager
Journal: Blood
Blood (2023) 142 (Supplement 1): 6808.
https://doi.org/10.1182/blood-2023-187722
Published: 2023
Journal Articles

Preclinical Evaluation of Allogeneic Anti-Bcma Chimeric Antigen Receptor T Cells with Safety Switch Domains and Lymphodepletion Resistance for the Treatment of Multiple Myeloma

Bijan Boldajipour, PhD, Roman Galetto, PhD, Cesar Sommer, PhD, Thomas Pertel, PhD, Julien Valton, PhD, Yoon Park, PhD, Annabelle Gariboldi, Amy Chen, Tao Geng, Hong H Dong, Gregory R Boucher, Thomas J Van Blarcom, PhD, Javier Chaparro-Riggers, PhD, Arvind Rajpal, PhD, Julianne Smith, PhD, Tracy Kuo, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2016) 128 (22): 381.
https://doi.org/10.1182/blood.V128.22.381.381
Published: 2016
Journal Articles

Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma

Siler H Panowski, PhD, Tracy Kuo, PhD, Amy Chen, Tao Geng, Thomas J Van Blarcom, PhD, Kevin Lindquist, PhD, Wei Chen, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2016) 128 (22): 383.
https://doi.org/10.1182/blood.V128.22.383.383
Published: 2016